Davriellelouna@lemmy.world to

News@lemmy.world · 18 hours ago

‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers

www.theguardian.com

cross-posted to:
globalnews@lemmy.zip

465

‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers

www.theguardian.com

Davriellelouna@lemmy.world to

News@lemmy.world · 18 hours ago

cross-posted to:
globalnews@lemmy.zip

As regulator prepares to approve Lenacapavir in the US, campaigners are urging the manufacturer, Gilead, to make it ‘available and affordable for all who need it’

Chat

gravitas_deficiency@sh.itjust.works
link
fedilink
English
arrow-up
75·
18 hours ago
Pharma C-suite:

that doesn’t sound very profitable

I fucking wish I was kidding
- 𝔼𝕩𝕦𝕤𝕚𝕒@lemmy.world
  link
  fedilink
  arrow-up
  8·
  15 hours ago
  “But how does this expand shareholder value”
- jonne@infosec.pub
  link
  fedilink
  arrow-up
  4
  arrow-down
  3·
  17 hours ago
  I mean, it doesn’t actually end it, to have to keep taking their pill. It’s a subscription model to life.
  - jeffw@lemmy.worldM
    link
    fedilink
    arrow-up
    14
    arrow-down
    1·
    16 hours ago
    
    Pill
    
    You could read the article before you comment lol
    - jonne@infosec.pub
      link
      fedilink
      arrow-up
      2·
      15 hours ago
      You caught me!

News@lemmy.world

news@lemmy.world

You are not logged in. However you can subscribe from another Fediverse account, for example Lemmy or Mastodon. To do this, paste the following into the search field of your instance: !news@lemmy.world

Welcome to the News community!

Rules:

1. Be civil

Attack the argument, not the person. No racism/sexism/bigotry. Good faith argumentation only. This includes accusing another user of being a bot or paid actor. Trolling is uncivil and is grounds for removal and/or a community ban. Do not respond to rule-breaking content; report it and move on.

2. All posts should contain a source (url) that is as reliable and unbiased as possible and must only contain one link.

Obvious right or left wing sources will be removed at the mods discretion. Supporting links can be added in comments or posted seperately but not to the post body.

3. No bots, spam or self-promotion.

Only approved bots, which follow the guidelines for bots set by the instance, are allowed.

4. Post titles should be the same as the article used as source.

Posts which titles don’t match the source won’t be removed, but the autoMod will notify you, and if your title misrepresents the original article, the post will be deleted. If the site changed their headline, the bot might still contact you, just ignore it, we won’t delete your post.

5. Only recent news is allowed.

Posts must be news from the most recent 30 days.

6. All posts must be news articles.

No opinion pieces, Listicles, editorials or celebrity gossip is allowed. All posts will be judged on a case-by-case basis.

7. No duplicate posts.

If a source you used was already posted by someone else, the autoMod will leave a message. Please remove your post if the autoMod is correct. If the post that matches your post is very old, we refer you to rule 5.

8. Misinformation is prohibited.

Misinformation / propaganda is strictly prohibited. Any comment or post containing or linking to misinformation will be removed. If you feel that your post has been removed in error, credible sources must be provided.

9. No link shorteners.

The auto mod will contact you if a link shortener is detected, please delete your post if they are right.

10. Don't copy entire article in your post body

For copyright reasons, you are not allowed to copy an entire article into your post body. This is an instance wide rule, that is strictly enforced in this community.

Visibility: Public

This community can be federated to other instances and be posted/commented in by their users.

4.11K users / day
9.12K users / week
14.4K users / month
33.3K users / 6 months
40 local subscribers
30.3K subscribers
27.8K Posts
692K Comments
Modlog